• FluTrackers.com Inc. does not provide medical advice. Information on this web site is collected from various internet resources, and the FluTrackers board of directors makes no warranty to the safety, efficacy, correctness or completeness of the information posted on this site by any author or poster. The information collated here is for instructional and/or discussion purposes only and is NOT intended to diagnose or treat any disease, illness, or other medical condition. Every individual reader or poster should seek advice from their personal physician/healthcare practitioner before considering or using any interventions that are discussed on this website. By continuing to access this website you agree to consult your personal physican before using any interventions posted on this website, and you agree to hold harmless FluTrackers.com Inc., the board of directors, the members, and all authors and posters for any effects from use of any medication, supplement, vitamin or other substance, device, intervention, etc. mentioned in posts on this website, or other internet venues referenced in posts on this website.
  • We are not asking for any donations. Do not donate to any entity who says they are raising funds for us.

The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza

tetano

Editor, Senior Moderator
Epidemiol Infect. 2015 Nov 27:1-9. [Epub ahead of print]
[h=1]The accuracy and timeliness of neuraminidase inhibitor dispensing data for predicting laboratory-confirmed influenza.[/h] Papenburg J[SUP]1[/SUP], Charland KM[SUP]2[/SUP], DE Serres G[SUP]3[/SUP], Buckeridge DL[SUP]1[/SUP].
[h=3]Author information[/h]

[h=3]Abstract[/h] Neuraminidase inhibitor (NI) dispensing has emerged as a possible automated data source for influenza surveillance. We aimed to evaluate its timeliness, correlation, and predictive accuracy in relation to influenza activity in Quebec, Canada, 2010-2013. Our secondary objective was to use the same metrics to compare NI dispensing to visits for influenza-like illness (ILI) in emergency departments (EDs). Provincial weekly counts of positive influenza laboratory tests were used as a reference measure for the level of influenza circulation. We applied ARIMA models to account for serial correlation. We computed cross-correlations to measure the strengths of association and lead-lag relationships between NI dispensing, ILI ED visits, and our reference indicator. Finally, using an ARIMA model, we evaluated the ability of NI dispensing and ILI ED visits to predict laboratory-confirmed influenza. NI dispensing was significantly correlated (R = 0?68) with influenza activity with no lag. The maximal correlation of ILI ED visits was not as strong (R = 0?50). Both NI dispensing and ILI ED visits were significant predictors of laboratory-confirmed influenza in a multivariable model; predictive potential was greatest when NI counts were lagged to precede laboratory surveillance by 2 weeks. We conclude that NI dispensing data provides timely and valuable information for influenza surveillance.


[h=4]KEYWORDS:[/h] Antiviral drugs; community pharmacies; influenza; multivariate analysis; public health surveillance

PMID: 26611607 [PubMed - as supplied by publisher]
 
Back
Top Bottom